Company NuGenerex Immuno-Oncology, Inc.
Equities
NUGX
US67053X1028
Biotechnology & Medical Research
Business Summary
Number of employees: 6
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Moscato
CEO | Chief Executive Officer | 61 | 16-12-31 |
Mark Corrao
DFI | Director of Finance/CFO | 67 | - |
Eric von Hofe
PSD | President | 66 | - |
Jason Terrell
CTO | Chief Tech/Sci/R&D Officer | 43 | - |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 17-01-17 |
Director/Board Member | 54 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Marvin Hausman
BRD | Director/Board Member | 82 | - |
Brian T. McGee
BRD | Director/Board Member | 63 | - |
Carol A. Nacy
BRD | Director/Board Member | 76 | - |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 17-01-17 |
Craig Eagle
BRD | Director/Board Member | 57 | - |
Joseph Moscato
CEO | Chief Executive Officer | 61 | 16-12-31 |
Director/Board Member | 54 | - | |
Thomas Leonard
BRD | Director/Board Member | 50 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 101,196,670 | 33,149,554 ( 32.76 %) | 0 | 32.76 % |
Company contact information
NuGenerex Immuno-Oncology, Inc.
10102 USA Today Way Suite 200
33025, Miramar
+(416) 364-2551
http://www.nugenerexio.comSector
1st Jan change | Capi. | |
---|---|---|
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-0.29% | 21.78B | |
-9.28% | 18.09B | |
-41.70% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |